Jennifer Kayden Lee, EVP, Head of North America at RHYTHM PHARMACEUTICALS, INC. (RYTM), sold 14,862 shares at $29.31 ($425K) on 2023-11-08, disclosed to the SEC on 2023-11-13.
Scheduled sale ($425k) by EVP, Head of North America under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.64 | 3,479 | $100K | 23.4% |
| 2 | $28.64 | 3,479 | $100K | 23.4% |
| 3 | $29.31 | 2,233 | $65K | 15.4% |
| 4 | $29.31 | 2,233 | $65K | 15.4% |
| 5 | $27.37 | 1,719 | $47K | 11.1% |
| 6 | $28.00 | 1,719 |
| $48K |
| 11.3% |
| Total | $28.62 avg | 14,862 | $425K | 100% |
| Filing → |
| RYTM | SELL | 2025-02-14 | $240K | — | Filing → |
| RYTM | SELL | 2025-02-11 | $611K | — | Filing → |
| RYTM | SELL | 2025-02-07 | $359K | — | Filing → |